RE: Golden Cross3 Sep 2025 09:48
12 months ago it was in the mid 70's, it collapsed to below 30p in May, several months into the P1b trial. Why was that?
The thing about this "partnership deal" in the not too distant future which is tied to P1b results could not be any vaguer.
What do the results need to be, what sums are we talking about, who is the deal going to be with and exactly what P1b data are we talking about? the end of the trial or at some undefined interim stage?
When is the not too distant future 2 weeks, 3 months, 12 months?
We still have not had the results yet from the P1a trial. It finished a year ago and obviously ran for the 3 or so years with data analytics at all stages of the trial, yet here we are 12 months later and still waiting for the collation. Is that the timescale this deal/partnership will be based on, the final collation of P1b data?
It still sounds to me that a RI is most likely given the lack of any meaningful info to any alternative.
The only thing we know for sure is that AVCT is committed to a January deadline to raise at least £13m.
The lack of finance was I believe the issue.
This latest recovery looks to be on the back of new external funding being easier to secure than previously envisioned.
The market will want more detail soon enough.
Hopefully all the warm words about P1b will be backed up by substance. As for a deal? Who knows, we won't have one or know its coming right up until it happens, (assuming it happens.) So its not forecastable.